[1] Banerjee U, Baloni P, Singh A, et al. Immune subtyping in latent tuberculosis[J]. Front Immunol, 2021, 12:595746. DOI: 10.3389/fimmu.2021.595746.
[2] Cohen SB, Gern BH, Urdahl KB. The tuberculous granuloma and preexisting immunity[J]. Annu Rev Immunol, 2022, 40:589-614. DOI: 10.1146/annurev-immunol-093019-125148.
[3] Wang Y, Sun Q, Zhang Y, et al. Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas[J]. J Infect, 2023, 86(5):421-438. DOI: 10.1016/j.jinf.2023.03.020.
[4] 吴志强,韩章琴,谭新良,等.莫西沙星联合卷曲霉素对耐多药肺结核患者炎性因子及免疫功能的影响[J].国际医药卫生导报,2017,23(12):1915-1918. DOI:10.3760/cma.j.issn.1007-1245.2017.12.032.
[5] Leong LY, Lin PC, Chi CY, et al. Risk factors of tuberculosis after liver transplant in a tertiary care hospital[J]. J Microbiol Immunol Infect, 2021, 54(2):312-318. DOI: 10.1016/j.jmii.2019.08.006.
[6] Lee YW, Chung H, Kim SH, et al. Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients[J]. Infection, 2024, 52(3):1055-1061. DOI: 10.1007/s15010-023-02161-1.
[7] Nguyen Van R, Houssel-Debry P, Erard D, et al. Characteristics, management, and outcome of tuberculosis after liver transplant: a case series and literature review[J]. Infect Dis Now, 2024, 54(3):104869. DOI: 10.1016/j.idnow.2024.104869.
[8] Albillos A, Martin-Mateos R, Van der Merwe S, et al. Cirrhosis-associated immune dysfunction[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(2):112-134. DOI: 10.1038/s41575-021-00520-7.
[9] Shan Y, Qi D, Zhang L, et al. Single-cell RNA-seq revealing the immune features of donor liver during liver transplantation[J]. Front Immunol, 2023, 14:1096733. DOI: 10.3389/fimmu.2023.1096733.
[10] Lucey MR, Furuya KN, Foley DP. Liver transplantation[J]. N Engl J Med, 2023, 389(20):1888-1900. DOI: 10.1056/NEJMra2200923.
[11] 赵东,唐建信,杨根东,等.肝移植术后肺部结核分枝杆菌感染的临床诊治分析[J/CD].实用器官移植电子杂志,2023,11(1):19-22. DOI:10.3969/j.issn.2095-5332.2023.01.005.
[12] 结核病分类WS 196—2017 Classification of tuberculosis[J].中国感染控制杂志,2018,17(4):367-368. DOI:10.3969/j.issn.1671-9638.2018.04.019.
[13] 赵玉沛.普通外科学[M].3版.北京:人民卫生出版社,2020:311-322.
[14] Toniutto P, Germani G, Ferrarese A, et al. An essential guide for managing post-liver transplant patients: what primary care physicians should know[J]. Am J Med, 2022, 135(2):157-166. DOI: 10.1016/j.amjmed.2021.08.005.
[15] Montano-Loza AJ, Rodríguez-Perálvarez ML, Pageaux GP, et al. Liver transplantation immunology: immunosuppression, rejection, and immunomodulation[J]. J Hepatol, 2023, 78(6):1199-1215. DOI: 10.1016/j.jhep.2023.01.030.
[16] Kumar N, Flores AS, Mitchell J, et al. Intracardiac thrombosis and pulmonary thromboembolism during liver transplantation: a systematic review and meta-analysis[J]. Am J Transplant, 2023, 23(8):1227-1240. DOI: 10.1016/j.ajt.2023.04.029.
[17] Lizaola-Mayo B, Vargas HE. Hepatorenal syndrome-acute kidney injury in liver transplantation[J]. Clin Gastroenterol Hepatol, 2023, 21(10S):S20-S26. DOI: 10.1016/j.cgh.2023.06.010.
[18] Malard F, Holler E, Sandmaier BM, et al. Acute graft-versus-host disease[J]. Nat Rev Dis Primers, 2023, 9(1):27. DOI: 10.1038/s41572-023-00438-1.
[19] Weeratunga P, Moller DR, Ho LP. Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis[J]. J Clin Invest, 2024, 134(1):e175264. DOI: 10.1172/JCI175264.
[20] Chandra P, Grigsby SJ, Philips JA. Immune evasion and provocation by mycobacterium tuberculosis[J]. Nat Rev Microbiol, 2022, 20(12):750-766. DOI: 10.1038/s41579-022-00763-4.
[21] Herrera MT, Guzmán-Beltrán S, Bobadilla K, et al. Human pulmonary tuberculosis: understanding the immune response in the bronchoalveolar system[J]. Biomolecules, 2022, 12(8):1148. DOI: 10.3390/biom12081148.
[22] Mosca M, Nigro MC, Pagani R, et al. Neutrophil-to-lymphocyte ratio (NLR) in NSCLC, gastrointestinal, and other solid tumors: immunotherapy and beyond[J]. Biomolecules, 2023, 13(12):1803. DOI: 10.3390/biom13121803.
[23] Buonacera A, Stancanelli B, Colaci M, et al. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases[J]. Int J Mol Sci, 2022, 23(7):3636. DOI: 10.3390/ijms23073636.
[24] 王来敏,谢兴宇.中性粒细胞/淋巴细胞比值在心力衰竭中的研究进展[J].心脏杂志,2024,36(1):97-100.DOI:10.12125/j.chj.202204028.
[25] 罗寒玉,冯俊,曹瑞,王本龙.NLR、PLR、MLR与冠状动脉疾病严重程度的相关性分析[J].广州医药,2023,54(11):30-35.DOI:10.3969/j.issn.1000-8535.2023.11.005.
[26] 陈仪,郑锡铭,张爱荣.外周血NLR、PLR水平与初诊多发性骨髓瘤患者预后的关系探讨[J].哈尔滨医药,2024,44(2):14-17.DOI:10.3969/j.issn.1001-8131.2024.02.005.
[27] van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives[J]. Nat Rev Cardiol, 2019, 16(3):166-179. DOI: 10.1038/s41569-018-0110-0.
[28] Scherlinger M, Richez C, Tsokos GC, et al. The role of platelets in immune-mediated inflammatory diseases[J]. Nat Rev Immunol, 2023, 23(8):495-510. DOI: 10.1038/s41577-023-00834-4.
|